Search Term:

*


June 1, 2021: Precision NanoSystems (PNI) has been acquired by Danaher Corporation’s Life Sciences platform.

April 1, 2021: Major capacity expansion underway to support increase in industry demand

March 31, 2021: New acquisition will help support single-use technology demand driven by COVID-19

January 7, 2021: Pall Corporation expands production capacity in the United States and Europe to support industry demand

Pall joins a consortium led by Oxford University in fast-tracking clinical trials for a COVID-19 vaccine beginning April 2020.

July 16, 2019: Servier chooses Pall as exclusive technology and services provider for planned Bio-S biomanufacturing facility in France

April 29, 2019: Freeline's (AAV) manufacturing platform and Pall’s iCELLis bioreactor system combine to achieve commercial-scale and high quality production of AAV gene therapy vectors

March 19, 2019: New lab will serve as a dedicated platform where the industry can access shared resources including equipment, expertise and project work to find innovative solutions to manufacturing needs for biologic medicines, such as cell-based immunotherapies

March 13, 2019: Pall Biotech to distribute ARTeSYN’s standard hardware and liner components for fluid flow control. Customers to benefit from the flexibility, agility and reliability required for their bioprocessing journey, with accelerated implementation of robust and standardized single-use fluid management and control